Echo Doppler (ED )Score and D-dimer (DD) Level in the Evaluation of VTE Recurrence After Anticoagulant Treatment Cessation (VAPRED)
Study of Predictive Echo Doppler Score and D-dimer Level in Evaluation of the Thromboembolic Event Recurrence After Anticoagulant Treatment Cessation.
Sponsor: University Hospital, Grenoble
This PHASE4 trial investigates Previous Proximal VTE and Previous Vka Treatment and is currently completed. University Hospital, Grenoble leads this study, which shows 7 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Oct 2025 — Present [monthly]
Completed PHASE4
-
Sep 2025 — Oct 2025 [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Mar 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Grenoble
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Amiens, France , Annecy, France , Bourgoin, France , Chalon-sur-Saône, France , Chambéry, France , Crolles, France , Fontaine, France , Grenoble, France , Meylan, France , Pontcharra, France and 3 more locations